These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6357983)

  • 21. The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man.
    Smith D; Pernet A; Reid H; Bingham E; Rosenthal JM; Macdonald IA; Umpleby AM; Amiel SA
    Diabetologia; 2002 Oct; 45(10):1416-24. PubMed ID: 12378383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin sensitivity in zinc-depleted rats: assessment with the euglycaemic hyperinsulinic clamp technique.
    Faure P; Roussel AM; Martinie M; Osman M; Favier A; Halimi S
    Diabete Metab; 1991; 17(3):325-31. PubMed ID: 1884875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects.
    Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A
    Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the biologic activity of porcine and semisynthetic human insulins using the glucose-controlled insulin infusion system in insulin-dependent diabetes.
    Szekeres A; Worcester B; Ascher MS; Tuxen D; Heyendal R; Walsh KM; Charles MA
    Diabetes Care; 1983; 6(2):193-6. PubMed ID: 6343025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the effects of semisynthetic human insulin and porcine insulin on transmembrane ion shifts and glucose metabolism during euglycaemic clamping.
    Heine RJ; Ponchner M; Hanning I; Home PD; Brown M; Williams D; Alberti KG
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):241-7. PubMed ID: 6375230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of porcine and semisynthetic human insulins using euglycemic clamp-derived glucose-insulin dose-response curves in insulin-dependent diabetes.
    Staten M; Worcester B; Szekeres A; Waldeck N; Ascher M; Walsh KM; Rizza R; Gerich J; Charles MA
    Metabolism; 1984 Feb; 33(2):132-5. PubMed ID: 6363874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.
    Ponchner M; Heine RJ; Pernet A; Hanning I; Francis AJ; Cook D; Orskov H; Alberti KG
    Diabetologia; 1984 Jun; 26(6):420-5. PubMed ID: 6381189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man.
    Waldhäusl WK; Bratusch-Marrain PR; Vierhapper H; Nowotny P
    Metabolism; 1983 May; 32(5):478-86. PubMed ID: 6341763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The action profiles of human NPH insulin preparations.
    Starke AA; Heinemann L; Hohmann A; Berger M
    Diabet Med; 1989 Apr; 6(3):239-44. PubMed ID: 2523785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the euglycaemic clamp technique to bioassay of insulin analogues.
    Vłlund A; Ribel U; Dam PL; Markussen J; Langkjaer L; Dolben J; Owens DR
    Biologicals; 1992 Jun; 20(2):135-42. PubMed ID: 1389109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential response to infusions of highly purified and conventional bovine and porcine insulins.
    Nosadini R; Noy G; Kurtz AB; Alberti KG
    Diabetes; 1981 Aug; 30(8):650-5. PubMed ID: 7018969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption of subcutaneously administered regular human and porcine insulin in different concentrations.
    Chantelau E; Sonnenberg GE; Rajab A; Römisch J; Berger M
    Diabete Metab; 1985 Apr; 11(2):106-10. PubMed ID: 3891442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological potency of porcine, bovine and human insulins in the rabbit bioassay system.
    Pingel M; Vølund A; Sørensen E; Collins JE; Dieter CT
    Diabetologia; 1985 Nov; 28(11):862-9. PubMed ID: 3910496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of platelet aggregation induced by euglycaemic insulin clamp.
    Hiramatsu K; Nozaki H; Arimori S
    Diabetologia; 1987 May; 30(5):310-3. PubMed ID: 3301481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal insulin--a dose response curve.
    Rubin J; Bell AH; Andrews M; Jones Q; Planch A
    ASAIO Trans; 1989; 35(1):17-21. PubMed ID: 2659049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men.
    Keen H; Glynne A; Pickup JC; Viberti GC; Bilous RW; Jarrett RJ; Marsden R
    Lancet; 1980 Aug; 2(8191):398-401. PubMed ID: 6105520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative assessment of the biological effects of semisynthetic human insulin and porcine insulin in healthy subjects].
    Stepka M; Rogala H; Kasperska-Dworak A; Wocial B; Jeske W
    Pol Arch Med Wewn; 1991 Dec; 86(6):372-81. PubMed ID: 1819787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs.
    Jendle JH; Karlberg BE; Arborelius M
    Scand J Clin Lab Invest; 1996 May; 56(3):251-8. PubMed ID: 8761529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat.
    Halban PA; Berger M; Gjinovci A; Renold AE
    Diabetes Care; 1981; 4(2):238-43. PubMed ID: 7011735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Thomas A
    MMW Fortschr Med; 2023 May; 165(10):28. PubMed ID: 37202684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.